Senior insider sale
CHIEF FINANCIAL OFFICER at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$450.7K
10.51K shares
What this filing means
CLINE CHRISTOPHER R. plans to sell 10.51K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $450.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/5/2026ACC: 0001193125-26-207099
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
10.51K
Shares to sell
$450.7K
Approx. market value
2.18K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Performance Restricted Stock Unit Vesting
Compensation
5/4/2026
2.18KTotal acquired2.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Performance Restricted Stock Unit Vesting Compensation | 2.18K | — |
| Total | 2.18K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
1.01K
Market value
$43.2K
4/15/2026
—Completed
Units to sell
9.00
Market value
$369.63
4/14/2026
—Completed
Units to sell
7.24K
Market value
$303.5K
4/14/2026
—Completed
Units to sell
65.00
Market value
$1.9K
4/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.18K
Market value
$101.7K
5/5/2026
Total
Units
10.51K
Value
$450.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/15/2026 | 1.01K | $43.2K | — | Completed |
4/14/2026 | 9.00 | $369.63 | — | Completed |
4/14/2026 | 7.24K | $303.5K | — | Completed |
4/13/2026 | 65.00 | $1.9K | — | Completed |
| Planned — Approximate Date | ||||
5/5/2026 | 2.18K | $101.7K | NASDAQ | Planned |
| Total | 10.51K | $450.7K | ||